Folate intake and bowel cancer risk

Area of Science:

• Biochemistry
• Nutritional Science
• Oncology

Background:

• Folate (vitamin B) is crucial for DNA synthesis and methylation.
• Epidemiological studies link higher folate intake to reduced colorectal cancer (CRC) risk.
• Mechanisms include preventing uracil incorporation into DNA and maintaining methylation patterns.

Purpose of the Study:

• To investigate the discrepancy between observational studies suggesting folate's protective effect against CRC and intervention studies showing no benefit.
• To explore potential adverse effects of high folic acid intake.

Main Methods:

• Review of epidemiological data and human intervention trials on folate and folic acid.
• Analysis of biological mechanisms related to folate metabolism and DNA integrity.

Main Results:

• Observational studies associate dietary folates with lower CRC risk.
• Intervention studies with high-dose folic acid (500-5,000 µg/day) did not show adenoma recurrence benefit.
• High folic acid intake (>400 µg/day) may lead to unmetabolized folic acid in blood, potentially causing adverse effects like reduced Natural Killer cell activity and increased prostate cancer risk.

Conclusions:

• The differing results may stem from using unphysiologically high doses of folic acid in interventions versus natural folates in diets.
• The benefit-risk of mandatory folic acid fortification remains unclear, with potential risks of inducing other cancers.
• Further mandatory folic acid fortification should be delayed pending clarification of its safety and efficacy.